The agreement will give patients access to Vertex's Orkambi and Symkevi as treatment options.
Vertex cystic fibrosis medicines are reimbursed in 17 countries including Austria, Australia, Denmark, Germany, the Republic of Ireland, Italy, the Netherlands, Sweden and the US.
Price: 173.11, Change: +2.10, Percent Change: +1.23
|Consensus for Zumiez Q2 Earnings Raised but Full Yea...|
|Williams Sonoma's Q2, 2021, 2022 Full Year Earnings ...|
|Analysts' Ratchet Up 2020, 2021 Consensus Estimates ...|
|Q1, 2021, 2022 Earnings Estimates for Advanced Drain...|
|Q2 Projection for Westlake Chemical Increased but 20...|